Power in the pivotal study (EU) [Power / Sample Size]

posted by valivetiananth – India, 2018-05-31 13:49 (911 d 00:14 ago) – Posting: # 18832
Views: 6,308

Dear All,

Greetings!!!

We have conducted a pivotal study for Europe with 48 subjects considering ~80% power, ISCV: 23%. The study was bioequivalent and 90% CI is within 80-125 for both Cmax & AUCt.

Power of Cmax and AUCt are 92% & 66% respectively. Kindly guide us how to justify the power less than 80% to HA.


Thanks
Valiveti

Complete thread:

Activity
 Admin contact
21,213 posts in 4,426 threads, 1,481 registered users;
online 13 (0 registered, 13 guests [including 9 identified bots]).
Forum time: Friday 13:04 CET (Europe/Vienna)

Biostatistician. One who has neither the intellect for mathematics
nor the commitment for medicine but likes to dabble in both.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5